Preparation of a compound for the treatment of Duchenne muscular dystrophy

Details for Australian Patent Application No. 2008286325 (hide)

Owner Summit Corporation PLC

Inventors De Moor, Olivier; Wynne, Graham Michael; Clarkson, Robert; Wren, Stephen Paul; Weymouth-Wilson, Alexander Charles; Van Well, Renate

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008286325

PCT Pub. Number WO2009/021749

Priority 0715937.9 15.08.07 GB

Filing date 14 August 2008

Wipo publication date 19 February 2009

International Classifications

C07D 263/57 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2009/021749 Priority application(s): WO2009/021749

11 March 2010 Assignment before Grant

  Summit Corporation PLC The application has been assigned to Biomarin IGA Limited

22 April 2010 Corrigenda

  Assignments Before Grant, Section 113 - 2008 Under the name Biomarin IGA Limited, Application No. 2008286325, under INID(71), correct the applicant name to BioMarin IGA Limited

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008286326-Treatment of Duchenne muscular dystrophy

2008286324-Polymorphs of a compound for the treatment of Duchenne muscular dystrophy